Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Noe

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Die Pharmazie|June 14, 2024
Quality evaluation of highly purified human menopausal gonadotropin preparations by means of gel electrophoresis and mass spectrometryL Muqaku, V Dorrer, M Noe, et al.
Die Pharmazie|March 9, 2013
Lactic acid oligomers (OLAs) as prodrug moietiesJ Kruse, B Lachmann, R Lauer, et al.
Neuroscience Letters|August 3, 1992
Interaction of long chain n-alkyl diamines with the NMDA receptor complexM L Berger, I Seifriz, M Letschnig, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 11, 1999
Synthesis of cholesterol modified cationic lipids for liposomal drug delivery of antisense oligonucleotidesA Zimmer, S A Aziz, M Gilbert, et al.
Die Pharmazie|May 4, 2010
Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro modelV Poetsch, B Bennani-Baiti, W Neuhaus, et al.
International Journal of Pharmaceutics|December 8, 2009
Characterization of two blood-brain barrier mimicking cell lines: distribution of lectin-binding sites and perspectives for drug deliveryV E Plattner, B Germann, W Neuhaus, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotidesH P Zobel, J Kreuter, D Werner, et al.
Archiv Der Pharmazie|July 1, 1980
[Thiophene as a structural element of physiologically active compounds, IV: o-Substituted 5-phenylthieno(2,3-e)(1,4)diazepines (author's transl)]D Binder, O Hromatka, C R Noe, et al.
Arzneimittel-Forschung|January 1, 1982
[Pyrazine-1,4-dioxides fused to heterocycles / 2nd comm.: Synthesis and antibacterial activity of substituted pyrido[2,3-b]pyrazine-1,4-dioxides (author's transl)]D Binder, A Georgopoulos, C R Noe, et al.
Brain Research|May 19, 2009
Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned mediaW Neuhaus, B Germann, V E Plattner, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Die Pharmazie|June 14, 2024
Quality evaluation of highly purified human menopausal gonadotropin preparations by means of gel electrophoresis and mass spectrometryL Muqaku, V Dorrer, M Noe, et al.
Die Pharmazie|March 9, 2013
Lactic acid oligomers (OLAs) as prodrug moietiesJ Kruse, B Lachmann, R Lauer, et al.
Neuroscience Letters|August 3, 1992
Interaction of long chain n-alkyl diamines with the NMDA receptor complexM L Berger, I Seifriz, M Letschnig, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 11, 1999
Synthesis of cholesterol modified cationic lipids for liposomal drug delivery of antisense oligonucleotidesA Zimmer, S A Aziz, M Gilbert, et al.
Die Pharmazie|May 4, 2010
Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro modelV Poetsch, B Bennani-Baiti, W Neuhaus, et al.
International Journal of Pharmaceutics|December 8, 2009
Characterization of two blood-brain barrier mimicking cell lines: distribution of lectin-binding sites and perspectives for drug deliveryV E Plattner, B Germann, W Neuhaus, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotidesH P Zobel, J Kreuter, D Werner, et al.
Archiv Der Pharmazie|July 1, 1980
[Thiophene as a structural element of physiologically active compounds, IV: o-Substituted 5-phenylthieno(2,3-e)(1,4)diazepines (author's transl)]D Binder, O Hromatka, C R Noe, et al.
Arzneimittel-Forschung|January 1, 1982
[Pyrazine-1,4-dioxides fused to heterocycles / 2nd comm.: Synthesis and antibacterial activity of substituted pyrido[2,3-b]pyrazine-1,4-dioxides (author's transl)]D Binder, A Georgopoulos, C R Noe, et al.
Brain Research|May 19, 2009
Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned mediaW Neuhaus, B Germann, V E Plattner, et al.
Pageof 5